Related references
Note: Only part of the references are listed.Investigation of the Discriminatory Ability of Pharmacokinetic Metrics for the Bioequivalence Assessment of PEGylated Liposomal Doxorubicin
Li-feng Hsu
PHARMACEUTICAL RESEARCH (2018)
Proposing the Use of Partial AUC as an Adjunctive Measure in Establishing Bioequivalence Between Deltoid and Gluteal Administration of Long-Acting Injectable Antipsychotics
Lik Hang N. Lee et al.
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS (2016)
Impact of Release Mechanism on the Pharmacokinetic Performance of PAUC Metrics for Three Methylphenidate Products with Complex Absorption
Andre Jackson
PHARMACEUTICAL RESEARCH (2014)
Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies
David Coghill et al.
BMC PSYCHIATRY (2013)
Use of Partial AUC (PAUC) to Evaluate Bioequivalence-A Case Study with Complex Absorption: Methylphenidate
Jeanne Fourie Zirkelbach et al.
PHARMACEUTICAL RESEARCH (2013)
Use of Partial Area under the Curve Metrics to Assess Bioequivalence of Methylphenidate Multiphasic Modified Release Formulations
Ethan M. Stier et al.
AAPS JOURNAL (2012)
Population pharmacodynamic modeling of various extended-release formulations of methylphenidate in children with attention deficit hyperactivity disorder via meta-analysis
Holly Kimko et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2012)
Single- and Multiple-Dose Pharmacokinetics of Methylphenidate Administered as Methylphenidate Transdermal System or Osmotic-Release Oral System Methylphenidate to Children and Adolescents With Attention Deficit Hyperactivity Disorder
David Pierce et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2010)
Comparative bioavailability of single-dose methylphenidate from a multilayer-release bead formulation and an osmotic system: A two-way crossover study in healthy young adults
Joseph L. Reiz et al.
CLINICAL THERAPEUTICS (2008)
Efficacy of two long-acting methylphenidate formulations in children with attention-deficit/hyperactivity disorder in a laboratory classroom setting
R Silva et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2005)
Pharmacokinetics of methylphenidate after oral administration of two modified-release formulations in healthy adults
JS Markowitz et al.
CLINICAL PHARMACOKINETICS (2003)
Measures of exposure versus measures of rate and extent of absorption
ML Chen et al.
CLINICAL PHARMACOKINETICS (2001)
Single- and multiple-dose pharmacokinetics of an oral once-a-day osmotic controlled-release OROS® (methylphenidate HCl) formulation
NB Modi et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2000)
Share Paper
